Navigation Links
Kevin Niksarli, M.D. Of Newsight Laser Center, New York, N.Y. Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6/17/2009
Date:6/20/2009

Kevin Niksarli, M.D. of Newsight Laser Center, New York, N.Y., states that glaucoma is one of the leading causes of blindness in the United States, affecting over 3 million Americans. As many as half of them do not even know they have the disease. That is because glaucoma - often called "the sneak thief of sight" - attacks silently, with no noticeable symptoms or warning signs until it has become well established, adds Dr. Niksarli.

New York, NY (PRWEB) June 20, 2009 -- Kevin Niksarli, M.D. of Newsight Laser Center, reminds on 6/17/2009 in a meeting in New York, N.Y., that early detection of glaucoma is critical to slowing the progress of the disease.

Glaucoma is one of the leading causes of blindness in the United States, affecting over 3 million Americans. As many as half of them do not even know they have the disease. That is because glaucoma - often called "the sneak thief of sight" - attacks silently, with no noticeable symptoms or warning signs until it has become well established.

As the disease progresses, people with glaucoma may notice their peripheral vision failing. By this time, the disease is usually quite advanced, and the damage is irreversible. Once vision or visual field is lost, it cannot be restored. Glaucoma usually affects both eyes, one eye shortly after the other, states Dr. Niksarli.

Although glaucoma is not preventable, it is treatable very effectively often with eye drops, especially if caught in its earliest stages. The surest way to detect the disease in its nascent sates is through a comprehensive eye examination. Immediate treatment for early-stage open-angle glaucoma can often delay or halt the progression of the disease.

Dr. Niksarli, notes that skipping regular and thorough eye examinations is chief among the barriers to early detection. A comprehensive examination can identify risk factors, such as high eye pressure and family history, before the disease even begins to take hold.

While anyone can develop glaucoma, regular examinations are critical in patients belonging to high-risk groups, such as those with high blood pressure, diabetes and those with a family history of the disease. Glaucoma is also more common in African Americans over 40 years of age and the general population over 60 years of age.

Kevin Niksarli, M.D. of Newsight Laser Center adds that when glaucoma cannot be controlled with eye drops, ophthalmologuists may turn to laser surgery in which a focused bean of light creates openings at certain inner part of the eye to make fluid drainage easier. The next line of treatment is a surgical procedure called a trabeculectomy, in which a small opening is made in the front chamber of the eye to produce a new pathway through which fluid can drain. Even with surgery, many patients with glaucoma still may need eye drops to keep the condition under check, as well as close supervision by their ophthalmologist, concludes Dr. Niksarli.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2551564.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. MedQuist Adds Kevin Piltz as New Chief Information Officer
2. Kevin Niksarli, M.D. of Manhattan Lasik Center Reviews Pros and Cons of Contact Lenses vs. iLASIK at an International Meeting on 7/1/2009
3. Kevin Niksarli, M.D. of Manhattan Lasik Center is to Discuss the iLASIK Procedure on AMWC Subspecialty Day Meeting on 7/1/2009
4. LASIK Specialist Board Certified Eye Surgeon Dr. Kevin Niksarli, M.D. of Manhattan Lasik Center Announces Website Update
5. Liu Young Investigator Award presented to Kevin Bruhn, Ph.D.
6. Strategic Diagnostics Appoints Kevin J. Bratton as Chief Financial Officer
7. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
8. Kevin Hutchinson Appointed to Health IT Standards Committee
9. LocumTenens.com Names Kevin Weeks as Vice President, Marketing
10. KevinMD.com Joins the HCPLive.com Network
11. Kevin Grossman Named President of HRmarketer.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... , ... CareSet Labs released the Root NPI Graph today at the 2017 ... improved version of the Doctor Referral teaming dataset commonly available from Medicare. , Originally ... the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by ...
(Date:6/25/2017)... ... June 25, 2017 , ... June is Men’s Health Month and the focus is ... among men in the U.S. and the third most common cause of cancer related death ... man in seven will be diagnosed with prostate cancer during his lifetime. Those at ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ Society’s ... and Erie Convention Center on June 8-10. The weekend consisted of many ... award and scholarship presentations, and professional networking. , On Friday June 9th, ...
(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... today announced the launch of Care Management Alerts and Dashboards, an innovative new ... throughout Rhode Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... Calif. , June 14, 2017 The ... the City of Fremont and ... of the bio-pharma industry in California ... technology, enabling executive networking, and fostering workforce development. The ... development and growth of start-ups, as well as small ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
Breaking Medicine Technology: